BAILLIE GIFFORD & CO 13D and 13G filings for 10x Genomics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-06-07 09:55 am Sale | 2024-05-31 | 13G | 10x Genomics, Inc. TXG | BAILLIE GIFFORD & CO | 2,777,115 2.630% | -5,142,861 (-64.94%) | Filing |
| 2024-01-29 11:43 am Sale | 2023-12-29 | 13G | 10x Genomics, Inc. TXG | BAILLIE GIFFORD & CO | 7,919,976 7.600% | -682,259 (-7.93%) | Filing |
| 2023-01-18 06:24 am Purchase | 2022-12-30 | 13G | 10x Genomics, Inc. TXG | BAILLIE GIFFORD & CO | 8,602,235 9.000% | 1,723,858 (+25.06%) | Filing |
| 2022-01-18 06:57 am Purchase | 2021-12-31 | 13G | 10x Genomics, Inc. TXG | BAILLIE GIFFORD & CO | 6,878,377 7.510% | 6,878,377 (New Position) | Filing |